BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Amerzhanova Y, Vangelista L. Filling the Gaps in Antagonist CCR5 Binding, a Retrospective and Perspective Analysis. Front Immunol 2022;13:826418. [DOI: 10.3389/fimmu.2022.826418] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Hillman T. A Predictive Model for Identifying the Most Effective Anti-CCR5 Monoclonal Antibody. Arch Pharm Pract 2023;14:40-49. [DOI: 10.51847/d9m2zufqr4] [Reference Citation Analysis]
2 Secchi M, Vangelista L. Rational Engineering of a Sub-Picomolar HIV-1 Blocker. Viruses 2022;14. [PMID: 36366513 DOI: 10.3390/v14112415] [Reference Citation Analysis]
3 Mukanova S, Borissenko A, Kim A, Bolatbek A, Abdrakhmanova A, Vangelista L, Sonnenberg-riethmacher E, Riethmacher D. Role of periostin in inflammatory bowel disease development and synergistic effects mediated by the CCL5–CCR5 axis. Front Immunol 2022;13:956691. [DOI: 10.3389/fimmu.2022.956691] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]